Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930381 · ClinicalTrials.gov registry record · NA
Adapting and Expanding the Asthma-Educator App
A NA study of Asthma, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03930381: Completed NA study of Asthma, sponsored by Montefiore Medical Center.
NCT03930381 is a NA study of Asthma that has completed, run by Montefiore Medical Center. The registered enrollment target is 80 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03930381, a NA study of Asthma, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This project seeks to test and refine an adapted/expanded version of a previously created ASTHMAXcel app.
Primary Outcome
Asthma symptom burden as measured by the Asthma Control Test Score Scale: 5 (min = worse); 25 (max = better outcome)
Conditions Studied
Interventions
- OTHER ASTHMAXcel App
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT03930381 record still lists
NCT03930381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which ASTHMAXcel App is the first listed.
NCT03930381 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03930381 about?
NCT03930381 is a clinical study titled "Adapting and Expanding the Asthma-Educator App". This project seeks to test and refine an adapted/expanded version of a previously created ASTHMAXcel app.
What is the current status of trial NCT03930381?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-05-01. Estimated completion is 2023-07-01.
What conditions does trial NCT03930381 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT03930381?
The interventions under investigation include: ASTHMAXcel App (OTHER).
Who is sponsoring clinical trial NCT03930381?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03930381 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03930381's enrollment target sits among peer trials
80 226th of 374 higher than 147 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI